Small Molecule for Pulmonary Hypertension
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT07175038
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2025
Completion: Mar 31, 2029
Loading map...